Connect with us
European Gaming Congress 2024

Artificial Intelligence

Global Functional Dyspepsia Drug Market to reach a valuation of US$ 16.4 billion by 2034, Future Market Insights, Inc. Projection

Published

on

global-functional-dyspepsia-drug-market-to-reach-a-valuation-of-us$-164-billion-by-2034,-future-market-insights,-inc.-projection

US functional dyspepsia drug market to grow at 5.1% CAGR till 2034. Rising GI disorders, aging population drive demand. Korea is set to be the top performing market, exhibiting a CAGR of 7.0% through 2034.
NEWARK, Del., May 1, 2024 /PRNewswire/ — The global functional dyspepsia drug market will reach a valuation of US$ 10.3 billion in 2024, attributed to factors such as increasing geriatric population. The trend is set to create new opportunities for the market, leading to a projected CAGR of 4.8% between 2024 and 2034, and reaching a total valuation of approximately US$ 16.4 billion by 2034.

Collaboration between pharmaceutical companies, academic institutions, and research organizations fosters innovation in functional dyspepsia drug development. Joint research efforts accelerate the discovery of novel therapeutic targets and the translation of scientific findings into clinical applications.
Request A Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-19518
Growing acceptance and utilization of complementary and alternative medicine approaches, such as herbal remedies, acupuncture, and mind body therapies, create opportunities for the development of natural or herbal based pharmacological treatments.
Investments in healthcare infrastructure, including the establishment of specialized gastrointestinal clinics and endoscopy centers, improve access to diagnostic services and specialist care for patients with functional dyspepsia. The infrastructure development supports the diagnosis and management of the condition, fuelling the market growth.
Harmonization of regulatory standards and the establishment of expedited approval pathways for gastrointestinal drugs across different regions streamline the drug development process.
It also facilitates market entry, encouraging investment in functional dyspepsia drug development. Research into the role of gut microbiota in gastrointestinal health has led to interest in developing drugs that modulate the microbiome to alleviate functional dyspepsia symptoms.
Probiotics, prebiotics, and fecal microbiota transplantation are areas of exploration, offering potential for novel treatment options. Advancements in regenerative medicine, including tissue engineering and stem cell therapies, offer potential for tissue repair and regeneration in gastrointestinal disorders like functional dyspepsia.
Regenerative approaches may provide long term therapeutic benefits and address underlying pathologies. Emphasis on patient reported outcomes and patient preferences in drug development processes promotes the development of drugs that align with patient needs and preferences.
Patient centric approaches enhance treatment satisfaction, adherence, and overall healthcare outcomes. The digitization of healthcare records and the widespread adoption of electronic health record systems facilitate data sharing and real time monitoring of patient outcomes.
Key Takeaways from the Market Study:
Global functional dyspepsia drug market was valued at US$ 9.7 billion in 2023.From 2019 to 2023, the market demand expanded at a CAGR of 6.5%.The market in Korea to expand at a CAGR of 7.0% through 2034.By indication, the functional dyspepsia segment to account for a CAGR of 4.6% through 2034.The market in China will expand at a CAGR of 5.5% through 2034.In terms of channel, the over the counter segment to account for a CAGR of 4.4% through 2034.”EHR integration with decision support tools enhances clinical decision making and improves the management of functional dyspepsia,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
Request Customization of Report: https://www.futuremarketinsights.com/customization-available/rep-gb-19518
Competitive Landscape:
The functional dyspepsia drug market is characterized by a diverse array of pharmaceutical companies, research institutions, and healthcare organizations striving to develop and commercialize innovative treatments for functional dyspepsia.
Company Portfolio:
Salix Pharmaceuticals, Inc. specializes in developing and commercializing gastrointestinal therapeutics for conditions such as functional dyspepsia. The company offers a range of products targeting different aspects of gastrointestinal health, including medications for symptom relief and disease management.Abbott Laboratories is a diversified healthcare company with a presence in various therapeutic areas, including gastroenterology. Abbott offers medications such as proton pump inhibitors, antacids, and digestive enzyme supplements.Report Scope:
Attribute
Details
Estimated Market Size in 2024
US$ 10.3 billion
Projected Market Valuation in 2034
US$ 16.4 billion
Value-based CAGR 2024 to 2034
4.8 %
Forecast Period
2024 to 2034
Historical Data Available for
2019 to 2023
Market Analysis
Value in US$ billion
Key Regions Covered

North AmericaLatin AmericaWestern EuropeEastern EuropeSouth Asia and PacificEast AsiaThe Middle East & AfricaKey Market Segments Covered

IndicationDrug TypeMedicationChannelDistribution ChannelRegionKey Countries Profiled

The United StatesCanadaBrazilMexicoGermanyFranceFranceSpainItalyRussiaPolandCzech RepublicRomaniaIndiaBangladeshAustraliaNew ZealandChinaJapanSouth KoreaGCC countriesSouth AfricaIsraelKey Companies Profiled

Advertisement

Takeda Pharmaceutical Company LimitedAstraZeneca plcSalix Pharmaceuticals Inc.Abbott LaboratoriesPfizer Inc.Sanofi SAProcter & GambleHaleon plcANI Pharmaceuticals, Inc.Dr. Reddy’s Laboratories Ltd. 
Get a Purchase on the Report: https://www.futuremarketinsights.com/checkout/19518
Segmentation Analysis of the Functional Dyspepsia Drug Market:
By Indication:
Functional DyspepsiaOrganic DyspepsiaBy Drug Type:
Proton Pump InhibitorsH-2-Receptor AntagonistsAntacidsAntibioticsProkineticsAntidepressantsBy Medication:
Branded MedicineGeneric MedicineBy Channel:
Over the CounterPrescriptionBy Distribution Channel:
Retail PharmaciesHospital PharmaciesOnline PharmaciesBy Region:
North AmericaLatin AmericaWestern EuropeEastern EuropeSouth Asia and PacificEast AsiaThe Middle East and AfricaAuthor By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:
General Anesthesia Drugs Market Size: The global general anesthesia drugs market size is estimated at US$ 4,978.1 million in 2023. Projections indicate a steady growth with a steady CAGR of 3.3% anticipated between 2023 and 2033. This trajectory is expected to lead the market to exceed US$ 6,898.4 million by 2033.
Psychotropic Drugs Market Share: The global Psychotropic Drugs Market size is US$ 21,269.4 million in 2023 and is expected to reach US$ 28,876.2 million by 2033. The global market is estimated to expand at a CAGR of 3.1% during the forecast period.
Lip Filler Market Growth: The lip filler market size is eyeing a valuation of US$ 738.2 million by 2034. The expansion is estimated at a 3.6% CAGR until 2034. In 2024, the valuation stands at US$ 518.3 million.
Nuclear Imaging Equipment Market Trends: The sales of nuclear imaging equipment are estimated to evolve at a CAGR of 5.4% between 2024 and 2034. The nuclear imaging equipment market size is expected to expand from US$ 3 billion in 2024 to US$ 5.1 billion through 2034.
Aesthetic Medical Device Market Outlook: The aesthetic medical device market is valued at US$ 13.73 billion in 2024 and is projected to reach US$ 18.82 billion by 2034, exhibiting a CAGR of 3.20% over the forecast period.
Infusion Pump Market Overview: The infusion pump market is expected to expand at a CAGR of 7.2% over the projected period. The market value is projected to increase from US$ 104.7 million in 2024 to US$ 209.8 million by 2034.
CTNG Testing Market Development: The CTNG testing market is projected to be worth US$ 1.8 billion in 2024. The market is anticipated to reach US$ 3.9 billion by 2034. The market is further expected to surge at a CAGR of 8.0% during the forecast period 2024 to 2034.
GLP-1 Receptor Agonist Market Strategy: The GLP-1 receptor agonist market is projected to be valued at US$ 23,854.53 million in 2024 and is expected to rise to US$ 72,127.79 million by 2034. It is expected to grow at a CAGR of 11.7% during the market forecast period.
Disposable Spinal Instrument Market Demand: The disposable spinal instrument market is expected to develop at a CAGR of 7.2% during the projected period. The market value is projected to increase from US$ 70.4 million in 2024 to US$ 141.1 million by 2034.
Ultrasound Conductivity Gel Market Forecast: The ultrasound conductivity gel market is estimated to be worth US$ 321.7 million in 2024. The market is expected to grow at a CAGR of 6.7% from 2024 to 2034. By the end of the forecast period, the market value is predicted to hit US$ 615.3 million.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us: Future Market Insights Inc.Christiana Corporate, 200 Continental Drive,Suite 401, Newark, Delaware – 19713, USAT: +1-845-579-5705For Sales Enquiries: [email protected]: https://www.futuremarketinsights.comLinkedIn | Twitter | Blogs | YouTube
Logo: https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/global-functional-dyspepsia-drug-market-to-reach-a-valuation-of-us-16-4-billion-by-2034–future-market-insights-inc-projection-302132027.html

Continue Reading
Advertisement

Artificial Intelligence

Glancing into Tomorrow at GITEX: e& UAE’S Vision for a Smarter, AI-powered Future

Published

on

glancing-into-tomorrow-at-gitex:-e&-uae’s-vision-for-a-smarter,-ai-powered-future

DUBAI, UAE, Oct. 14, 2024 /PRNewswire/ — As e& UAE prepares to make an impact at GITEX Global, the company’s momentum is undeniable. Fresh off the heels of being crowned ‘World’s Fastest 5G Network’ by Ookla, e& UAE is poised to showcase the cutting-edge innovations stemming from its state-of-the-art telco core. 

e& UAE serves 5G to 12 million active users every day bringing to the forefront of global connectivity. “High-speed networks are crucial for connecting the dots between AI components, including transferring data and accessing cloud-based resources,” says Masood. “In essence, AI is a product of a sophisticated infrastructure that combines hardware, software, and networking to enable the development and deployment of intelligent systems,” Masood says.
For e& UAE, this means continually embracing AI as a key component of its innovation strategy. The company has a successful history of implementing AI solutions to drive productivity and enhance customer experiences, and, as Masood puts it, “AI is where we see the real potential for transformation.”
It’s with this vision in mind that e& UAE plans to make its mark at GITEX, showcasing its latest AI innovations and demonstrating its leadership in the digital landscape.
More than a telco: e& UAE’s digital leap
“AI is embedded across our operations, enabling smarter, faster decision-making and driving new efficiencies in business and customer service,” he says. e& UAE was a pioneer in adopting AI internally, but its true impact lies in delivering exceptional digital experiences to customers. A prime example is EASE, the world’s first autonomous telecom retail experience, launched at GITEX last year. Since then, e& UAE has rapidly expanded the reach and capabilities of this innovative concept, demonstrating its commitment to leveraging AI for customer-centric solutions.
The company is actively building its reputation as a digital leader, offering cutting-edge connectivity solutions powered by 5G and AI and IoT integrations. This strategic shift is at the heart of e& UAE’s participation at GITEX, where the company will showcase its innovative digital offerings and vision for the future.
GITEX spotlight
“We’re thrilled to be part of GITEX, an exciting showcase of the future where the world’s greatest minds come together to envision and shape the technology of a better tomorrow,” Masood says.
In addition to the latest smart home solutions and drone technology, its showcase will include advanced applications in AI, augmented reality, and 5G technology, reflecting its commitment to digital transformation. One of the standout features will be the Hologram Customer Service Avatar, which aims to provide an interactive customer experience. This avatar will utilise ultra-HD, intelligent capabilities to facilitate real-time interactions, allowing users to engage with services in a more immersive manner. The integration of 5G New Calling technology will further enhance user experience by offering visualised voice calling, real-time translation, and multimedia content during calls.
Continuing the tradition of announcing 5G milestones at previous GITEX events, e& UAE announced network speed upgrades including the fastest aggregated 5G-Advanced speed of 62Gbps. Demonstrating its commitment to 5G leadership, e& UAE will also highlight its achievement as the largest 5G-Advanced commercial network in the MENA region, with over 1,000 operational sites. This milestone marks the dawn of the 10G era, delivering unparalleled speeds and ultra-low latency that will redefine digital experiences. At GITEX, it will not only showcase its impressive technological advancements but also unveil strategic partnerships that align with its vision for a digital future. Building upon the success of its 5G private network deployment in the oil and gas sector with ADNOC, the company is now expanding its reach in more industries.
“The success of AI, IoT, and 5G depends on building an ecosystem of innovation. That means working closely with tech giants, startups, and government entities to ensure we’re building the right solutions for the future,” says Masood.
Making networks AI-ready
At the heart of e& UAE’s mission to pioneer the digital frontier in the UAE lies a firm commitment to high-speed connectivity. For example, 50G-PON, the next generation of high-speed connectivity, promises to revolutionise internet connectivity, delivering unprecedented capacity and considerably speeding things up for consumers and businesses.
“Our strategy is rooted in a profound belief that we can achieve more for the people and communities we serve—drive more growth, create more opportunities, and have a greater impact—infused with a passion for excellence. As we evolve beyond traditional telecom, we are enhancing our services and tailoring our offerings to meet the diverse needs of our customers.
The UAE’s global leadership in broadband and mobile speeds, as recognised by Ookla, is significantly attributed to the contributions of e& UAE. “We are part of the UAE fabric, and we stand with the country, helping to build a stronger, more connected society,” Masood concludes.
Contact details: Nancy Sudheer, Senior Manager at e&, [email protected] 
Photo – https://mma.prnewswire.com/media/2529931/e_GITEX_2024.jpgPhoto – https://mma.prnewswire.com/media/2529932/stand_GITEX.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/glancing-into-tomorrow-at-gitex-e-uaes-vision-for-a-smarter-ai-powered-future-302275312.html

Continue Reading

Artificial Intelligence

Security and Vulnerability Management Market worth $24.04 billion by 2030- Exclusive Report by MarketsandMarkets™

Published

on

security-and-vulnerability-management-market-worth-$24.04-billion-by-2030-exclusive-report-by-marketsandmarkets™

DELRAY BEACH, Fla., Oct. 14, 2024 /PRNewswire/ — The global Security and Vulnerability Management Market size is projected to grow from USD 16.51 billion in 2024 to USD 24.04 billion by 2030 at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period, according to new research report by MarketsandMarkets™.

Browse in-depth TOC on “Security and Vulnerability Management Market ”
250 – Tables 50 – Figures300 – Pages
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=204180861
Scope of the Report
Report Metrics
Details
Market size available for years
2018-2030
Base year considered
2023
Forecast period
2024–2030
Forecast units
Value (USD Billion) 
Segments Covered
Component, Software, Services, Type, Target, Deployment Mode, Organization Size, Vertical, And Region
Geographies covered
North America, Europe, Asia Pacific, Middle East & Africa, Latin America  
Companies covered
Major vendors in the global Security and vulnerability management  Microsoft (US), AT&T (US), CrowdStrike (US), IBM (US), Tenable (US), Cisco (US), DXC Technology (US), Check Point Software Technologies (Israel), Rapid7 (US), Qualys (US), ManageEngine (US), RSI Security (US), Fortra (US), Ivanti (US), Tanium (US), Invicti (US), Outpost24 (Sweden), Skybox Security (US), Vulcan Cyber (Israel), SecPod (India), Balbix (US), Intruder (UK), Brinqa (US), Holm Security (Sweden), Nucleus Security (US), and NopSec (US)
High financial losses due to security breaches and the growing demand for real-time monitoring and continuous vulnerability assessment drive the Security and Vulnerability Management Market. Organizations are thus striving to minimize these financial risks and they demand for robust security and vulnerability management solutions to strengthen their security posture.
Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=204180861
Based on the offerings, the solutions segment accounts for the largest market size during the forecast period.
According to PT Security, 98% of web applications are vulnerable to attacks resulting in malware, redirection to malicious websites, and more. This rising complexity of such cyber risks has spurred the demand for comprehensive security and vulnerability management solutions. The shift to cloud computing and remote work has amplified the demand for adaptive security tools, with AI-driven analytics and automation strengthening their role in security and vulnerability management. Furthermore, providers such as Microsoft, IBM, Qualys, Tenable, Rapid7, and CrowdStrike offering advanced security and vulnerability management solutions also contribute to position solutions as the largest market segment during the forecast period.
By the organization size segment, the SME segment is expected to grow at the highest CAGR during the forecast period.
The SME segment is expected to grow at the highest rate in the Security and Vulnerability Management Market due to increasing digital transformation, which exposes these businesses to heightened cyber threats. Most SMEs lack the resources and expertise of larger organizations, thus becoming vulnerable to cyber-attacks. Growing regulatory compliance requirements and the affordability of effective security solutions drive SMEs to invest in robust protection measures. As awareness about security risks grows, SMEs focus more on security investments, fueling rapid growth in this market segment.
Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=204180861
By region, North America accounts for the largest market size during the forecast period.
North America is expected to hold the most significant Security and Vulnerability Management Market, driven by its advanced digital infrastructure and the increasing frequency of cyber threats. Cybersecurity technologies have a high adoption rate in the region, and many established vendors make it relatively easier for organizations to implement integrated security measures. Strict regulatory frameworks also make companies have stringent vulnerability management practices to comply with the regulatory requirements and strengthen their security posture. The rapid growth of cloud computing, IoT, and digital transformation agendas further propels the demand for advanced solutions, amplifying North America’s stronghold in this market.
Top Key Companies in Security and Vulnerability Management Market:
Microsoft (US), AT&T (US), CrowdStrike (US), IBM (US), Tenable (US), Cisco (US), DXC Technology (US), Check Point Software Technologies (Israel), Rapid7 (US), Qualys (US), ManageEngine (US), RSI Security (US), Fortra (US), Ivanti (US), Tanium (US), Invicti (US), Outpost24 (Sweden), Skybox Security (US), Vulcan Cyber (Israel), SecPod (India), Balbix (US), Intruder (UK), Brinqa (US), Holm Security (Sweden), Nucleus Security (US), and NopSec (US) are the key players and other players in the Security and Vulnerability Management Market.
Browse Adjacent Markets: Information Security Market Research Reports & Consulting
Related Reports:
Quantum Cryptography Market – Global Forecast to 2030
Public Safety and Security Market – Global Forecast to 2029
Post-Quantum Cryptography (PQC) Market – Global Forecast to 2029
Network Security Market – Global Forecast to 2029
Security Testing Market – Global Forecast to 2029
Get access to the latest updates on Security and Vulnerability Management Companies and Security and Vulnerability Management Industry
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress Ave.Suite 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: [email protected] Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

View original content:https://www.prnewswire.co.uk/news-releases/security-and-vulnerability-management-market-worth-24-04-billion-by-2030–exclusive-report-by-marketsandmarkets-302274888.html

Continue Reading

Artificial Intelligence

OpenCorporates Appoints tech-entrepreneur Wojtek Kokoszka as New CEO, Founder Chris Taggart to Step into strategic innovation role for Partnerships and New Opportunities

Published

on

opencorporates-appoints-tech-entrepreneur-wojtek-kokoszka-as-new-ceo,-founder-chris-taggart-to-step-into-strategic-innovation-role-for-partnerships-and-new-opportunities

LONDON, Oct. 14, 2024 /PRNewswire/ — Following on from an exceptional 2024 performance, OpenCorporates, the world’s largest open database of legal entities, is excited to announce the appointment of Wojtek Kokoszka as its new Chief Executive Officer. Wojtek, a seasoned entrepreneur and co-founder of Zappi, the leading SaaS Consumer Insights platform, brings a wealth of experience in scaling high-growth businesses and innovation in data-driven industries, both in Europe and the US.

 
 
Wojtek joins OpenCorporates with the clear mission to scale the world’s authoritative source of legal-entity data. At Zappi, Wojtek played a pivotal role in growing the company to $100 million in revenue. Under his leadership, Zappi transformed into an industry-leading platform that revolutionized how global consumer brands harness data to derive actionable insights. His track record of driving performance, fostering innovation, and executing strategic vision makes him ideally suited to lead OpenCorporates into its next phase of fast growth.
Chris Taggart, co-founder and outgoing CEO of OpenCorporates, will take on a strategic role as Founder focused on opening up new markets and opportunities. Chris will bring his exceptional domain knowledge and heritage to reinforce OpenCorporates’ position as the world’s most authoritative source of legal entity data. His leadership and vision have been instrumental in building the company from its inception, and he will continue to guide its mission to make company data open, transparent, and accessible to all.
Wojtek Kokoszka, Incoming CEO of OpenCorporates, commented:”I’m thrilled to join OpenCorporates at such an exciting time in its journey. OpenCorporates has established itself as the trusted authority in its space, and I look forward to driving us forward. We are going to deliver ever more quickly on our mission to provide certainty and clarity through our open, reliable, and transparent legal-entity data. I look forward to building on the very strong foundation created by Chris and the team, scaling our operations, and driving innovation to serve the ever-growing demand for high-quality, trustworthy data across public and private sector organisations.”
Chris Taggart, Founder of OpenCorporates, added:”In Wojtek Kokoszka, we have found a leader who will take OpenCorporates to new heights. His expertise in scaling businesses and operational excellence makes him the ideal choice for this role. This also frees me to focus on our strategic vision and work alongside him to explore new markets and ensure OpenCorporates remains at the forefront of corporate transparency. Legal entities are at the heart of the modern world – and as we move into a world of digitalized commerce and AI-generated uncertainty, OpenCorporates will be there to provide the trusted foundational data the world needs.”
About OpenCorporatesOpenCorporates is a certified B Corp, revolutionizing access to company data. It has built the world’s largest open database of companies, and is trusted by regulators, financial institutions, investigative journalists, and businesses for its unparalleled breadth of data, covering over 200 million companies across 140+ jurisdictions, including the entirety of the USA. This leadership transition marks an important milestone as the company continues to scale, innovate, and drive positive change by promoting transparency in the corporate world.
For more information, please contact:
Press Contact:Jackson TorchiaCommunity Manager at [email protected] 
Logo – https://mma.prnewswire.com/media/1709363/4965689/OpenCorporates_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/opencorporates-appoints-tech-entrepreneur-wojtek-kokoszka-as-new-ceo-founder-chris-taggart-to-step-into-strategic-innovation-role-for-partnerships-and-new-opportunities-302275220.html

Continue Reading
Advertisement
Advertisement

Latest News

Trending